Physical Training Program in Patients Hospitalized for Community-acquired Pneumonia

Overview

Hospitalized patients with community-acquired pneumonia (CAP) have reduced functional capacity, peripheral muscle strength and quality of life. Despite the high incidence and severity has not yet been demonstrated whether a physical training program can change these outcomes. Objectives: To evaluate the effects of an exercise training program in patients hospitalized for CAP, to compare this effects with traditional physical therapy and assess whether the inflammatory markers correlate with the functional status of the patient and type of treatment. Methods: A controlled, prospective, randomized clinical trial. Patients hospitalized for CAP, adults, conscious, hemodynamically stable and independent to walk will be studied. In the first day, a medical history, measured dyspnea, incremental shuttle walk test, Glittre test, measurement of peripheral muscle strength, spirometry, and the application of quality of life questionnaire Shor Form 36 will be held. The measurement of inflammatory markers (C-reactive protein and tumor necrosis factor) will also be held. Patients will be randomized into two groups: one will perform a program of physical training (stretching, active resistance exercises and aerobic exercises) and the other group held the traditional physical therapy (bronchial hygiene, breathing exercises and walking) for eight days. On the tenth day the same assessment will be carried out initially described.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: November 2014

Interventions

  • Other: Experimental group
    • Exercise Training Group
  • Other: Control group
    • Exercise control group

Arms, Groups and Cohorts

  • Experimental: Experimental group
    • Patients hospitalized for community-acquired pneumonia
  • Active Comparator: Control group
    • Patients hospitalized for community-acquired pneumonia

Clinical Trial Outcome Measures

Primary Measures

  • Glittre test
    • Time Frame: up to 9 months

Secondary Measures

  • Shuttle test
    • Time Frame: up to 9 months

Participating in This Clinical Trial

Inclusion Criteria

  • Clinical diagnosis of pneumonia
  • Must be able to walk
  • Time less than 48 hours of hospitalization
  • Age above 18 years
  • Conscious and oriented
  • Hemodynamically stable

Exclusion Criteria

  • Patients with other respiratory diseases
  • Osteoarticular or cognitive disorders
  • Patients who refuse to participate or complete the procedures

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Nove de Julho
  • Provider of Information About this Clinical Study
    • Principal Investigator: Anderson José, Prof. – University of Nove de Julho
  • Overall Official(s)
    • Simone Dal Corso, PhD, Study Director, University of Nove de Julho

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.